Participation in Australian drug treatment programs for individuals engaging in high‐risk substance use: Data from a nationally representative sample

Abstract

AbstractIntroductionSubstance use, including drugs, alcohol and smoking have a significant health, social and economic impact. We aim to assess the rate and factors associated with treatment access among individuals with high‐risk substance use.MethodThis study is a cross‐sectional analysis of the 2019 Australian National Drug Strategy Household Survey (N = 22,015). Participants were persons with high‐risk substance use based on the Alcohol, Smoking and Substance Involvement Screening Test—Lite (ASSIST‐Lite) and current smokers. We measured self‐reports of past 12‐month engagement in a tobacco, alcohol or other drugs treatment program.ResultsOverall, 0.4% had high‐risk drug use (0.3% cannabis, 0.1% meth/amphetamine or 0.1% opioids), 7.4% had high‐risk alcohol use, and 14.0% currently smoked. Among high‐risk users, past 12‐month treatment access rates were 50.6% [22.3–78.9%] for opioids, 27.1% [8.1–46.1%] for meth/amphetamine, 14.5% [4.3–24.7%] for cannabis, 9.6% [8.1–11.0%] for alcohol and 11.7% [10.6–12.9%] for current smoking. The primary source of treatment support was information and education (12.7% drugs, 4.6% alcohol, 4.0% smoking), followed by counselling (6.7% drugs, 4.5% alcohol, 3.0% smoking). Online or internet support was accessed by 5.9% (drug) and 1.6% (alcohol) people with high‐risk use. Psychological distress was associated with treatment access (drugs: odds ratio 3.03 [0.77–11.95], p = 0.111; alcohol: odds ratio 3.16 [2.20–4.56], p ≤ 0.001; smoking: odds ratio 1.95 [1.52–2.49], p ≤ 0.001).Discussion and ConclusionsThe proportion of people engaging in risky substance use who had used treatment programs remains low, especially for alcohol. Public health strategies to scale up treatment access are warranted.